These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5299875)

  • 1. Postoperative changes in the trypsin inhibitor activities of human pancreatic juice and the influence of infusion of Trasylol on the inhibitor activity.
    Morgan A; Robinson LA; White TT
    Am J Surg; 1968 Feb; 115(2):131-9. PubMed ID: 5299875
    [No Abstract]   [Full Text] [Related]  

  • 2. [Postoperative changes in trypsin inhibitor activity in pancreatic secretion in the human and the effect of Trasylol].
    Dinstl K; White TT; Morgan A; Suda Y
    Langenbecks Arch Chir; 1969; 325():353-6. PubMed ID: 5309039
    [No Abstract]   [Full Text] [Related]  

  • 3. Postoperative changes in the trypsin inhibitor activity of human pancreatic juice and the influence of infusions of a parotid trypsin inhibitor extract (Trasylol, Bayer).
    White TT; Morgan A; Suda Y
    Bull Soc Int Chir; 1970; 29(3):164-8. PubMed ID: 5312587
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modifications of the activity of the trypsin inhibitor in human pancreatic juice after intervention and effect of perfusions of parotid trypsin inhibitors ("Trasylol", Bayer)].
    White TT; Morgan A; Suda Y
    Lyon Chir; 1969; 65(1):119-21. PubMed ID: 5305800
    [No Abstract]   [Full Text] [Related]  

  • 5. Pancreatic secretory trypsin inhibitor, cathodal trypsin, and pancreatic elastase in pancreatic juice collected at endoscopic retrograde cholangiopancreatography.
    Marks WH; Ohlsson K; Wehlin L; Russick C
    Curr Surg; 1985; 42(1):26-8. PubMed ID: 3844336
    [No Abstract]   [Full Text] [Related]  

  • 6. Aprotinin therapy as prophylaxis against postoperative pancreatitis in humans. A controlled evaluation.
    Skinner DB; Corson JG; Nardi GL
    JAMA; 1968 Jun; 204(11):945-8. PubMed ID: 5300957
    [No Abstract]   [Full Text] [Related]  

  • 7. [CLINICAL ASPECTS OF ACTIVATION OF NEUTRALIZED PANCREATIC ENZYMES].
    KADOLSKY A
    Dtsch Med J; 1964 Mar; 15():212-7. PubMed ID: 14187131
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of contrical introduced into Wirsung's duct on the morphofunctional response of the pancreas in acute experimental pancreatitis].
    Panchenkov RT; Penin VA; Kuznetsov EV
    Farmakol Toksikol; 1977; 40(3):333-6. PubMed ID: 302802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mode of action of a protease inhibitor on pancreatic enzymes].
    Blümel G; Piza F
    Wien Klin Wochenschr; 1966 Oct; 78(40):660-5. PubMed ID: 5298341
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
    Marks WH; Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of Trasylol on pancreatic secretion].
    Schönbach G; Sailer FX; Stamm D; Kümmel G; M4oller HD
    Klin Wochenschr; 1966 Jun; 44(11):652-3. PubMed ID: 5299632
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in pancreas secretion caused by trasylol].
    Sailer FX; Schönbach G; Kümmel G
    Langenbecks Arch Chir; 1966; 316():513-5. PubMed ID: 5298731
    [No Abstract]   [Full Text] [Related]  

  • 13. [The relationship between the secretion and incretion of pancreatic enzymes and the type of alimentary stimuli].
    Korot'ko GF; Sarkisova AS
    Fiziol Zh SSSR Im I M Sechenova; 1973 Oct; 59(10):1574-81. PubMed ID: 4787869
    [No Abstract]   [Full Text] [Related]  

  • 14. Trypsin, trypsinogen and trypsin inhibitor in human pancreatic juice.
    HAVERBACK BJ; DYCE B; BUNDY H; EDMONDSON HA
    Am J Med; 1960 Sep; 29():421-33. PubMed ID: 13852165
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in some blood biochemical indices in various functional states of the pancreas].
    Fenina EP; Anoshina AA; Bannikova NA
    Biull Eksp Biol Med; 1972 Feb; 13(2):41-3. PubMed ID: 5012999
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrapancreatic activation of proteases in the etiology of pancreatitis and cancer of the pancreas.
    White TT; Allan BJ
    Med Clin North Am; 1974 Nov; 58(6):1305-10. PubMed ID: 4610295
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitation of some pancreatic juice exocrine proteins in the presence of radiocontrast medium used in endoscopic retrograde pancreatography (ERP).
    Marks WH; Wehlin L; Ohlsson K; Russick C
    Endoscopy; 1984 Nov; 16(6):211-3. PubMed ID: 6439548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of the activity of trypsin and its inhibitors in biological fluids].
    Chernikova LG
    Lab Delo; 1971; 1():38-40. PubMed ID: 4110726
    [No Abstract]   [Full Text] [Related]  

  • 19. Enterokinase induced pancreatitis: its prevention with Trasylol and soybean trypsin inhibitor.
    Mann NS; Kadian RS; Narenderan K
    Am J Proctol Gastroenterol Colon Rectal Surg; 1978; 29(6):13-7. PubMed ID: 316652
    [No Abstract]   [Full Text] [Related]  

  • 20. [The nature of pancreatitis in dogs losing pancreatic juice and the participation of pancreatic juice components in regulating serum protein composition].
    Fenina EP
    Eisei Shikenjo Hokoku; 1970; 88():671-5. PubMed ID: 5533935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.